| DS | dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul... |
|---|---|
| Tabs | tablets |
| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
| TS | Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str... |
| US/LS | upper strength/lower strength [ratio] |
| CAHPS | Consumer Assessment of Health Plan Study |
|---|---|
| CPSC | Consumer Product Safety Commission |
| DTC | Direct to consumer |
| DTS | Diametral tensile strength |
| ES | Ego Strength |
| consumer advocacy | The promotion and support of consumers' rights and interests. (12 Dec 1998) |
|---|---|
| consumer organizations | Organised groups of users of goods and services. (12 Dec 1998) |
| consumer participation | Community or individual involvement in the decision-making process. (12 Dec 1998) |
| consumer satisfaction | Customer satisfaction or dissatisfaction with a benefit or service received. (12 Dec 1998) |
| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
| maximum | 1. The greatest possible or actual effect or quantity. 2. The acme of a disease or process. (18 Nov 1997) |
| maximum breathing capacity | The volume of air breathed when an individual breathes as deeply and as quickly as possible for a given time (e.g., 15 sec.). Synonym: maximum breathing capacity. (05 Mar 2000) |
| maximum occipital point | The point on the squama of the occipital bone farthest from the glabella. (05 Mar 2000) |
| maximum permissible dose | <radiobiology> Defined by the International Commission on Radiological Protection as the greatest dose of radiation which, in the light of present knowledge, is not expected to cause detectable bodily injury to a person at any time during his lifetime. This dose has been reduced with each Commission report. The MPD is given in terms of acute or chronic exposure of the whole body or of organs, systems, or regions of the body, and differs for persons who are occupationally exposed versus the public at large. (05 Mar 2000) |
| maximum permissible exposure level | The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury. (12 Dec 1998) |
| maximum temperature | In bacteriology, denoting a temperature above which growth will not take place. (05 Mar 2000) |
| maximum urea clearance | The urea clearance when the urine flow exceeds 2 ml/min; normal value is about 75 ml blood/min per 1.73 m2 body surface area. (05 Mar 2000) |
| maximum velocity | The maximum rate of an enzyme-catalyzed reaction that can be achieved by progressively increasing the substrate concentration at a given enzyme concentration; in cases of substrate inhibition, Vmax is an extrapolated value in the absence of such inhibition; Cf.: Michaelis-Menten equation. The maximum initial rate of shortening of a myocardial fibre that can be obtained under zero load; used to evaluate the contractility of the fibre. (05 Mar 2000) |
| maximum voluntary ventilation | The volume of air breathed when an individual breathes as deeply and as quickly as possible for a given time (e.g., 15 sec.). Synonym: maximum breathing capacity. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|